| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |